DK2246051T3 - Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel - Google Patents
Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddelInfo
- Publication number
- DK2246051T3 DK2246051T3 DK09705447.2T DK09705447T DK2246051T3 DK 2246051 T3 DK2246051 T3 DK 2246051T3 DK 09705447 T DK09705447 T DK 09705447T DK 2246051 T3 DK2246051 T3 DK 2246051T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidafenacin
- preparation
- active ingredient
- dissolving tablet
- oral fast
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- SQKXYSGRELMAAU-UHFFFAOYSA-N imidafenacin Chemical compound CC1=NC=CN1CCC(C(N)=O)(C=1C=CC=CC=1)C1=CC=CC=C1 SQKXYSGRELMAAU-UHFFFAOYSA-N 0.000 title 1
- 229950005396 imidafenacin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008020183 | 2008-01-31 | ||
PCT/JP2009/051651 WO2009096559A1 (ja) | 2008-01-31 | 2009-01-30 | イミダフェナシンを有効成分とする口腔内速崩錠の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2246051T3 true DK2246051T3 (da) | 2014-01-13 |
Family
ID=40912901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09705447.2T DK2246051T3 (da) | 2008-01-31 | 2009-01-30 | Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel |
Country Status (10)
Country | Link |
---|---|
US (1) | US8722133B2 (da) |
EP (1) | EP2246051B1 (da) |
JP (1) | JP4656672B2 (da) |
KR (1) | KR101528953B1 (da) |
CN (1) | CN101983055B (da) |
CA (1) | CA2713677A1 (da) |
DK (1) | DK2246051T3 (da) |
ES (1) | ES2444718T3 (da) |
PT (1) | PT2246051E (da) |
WO (1) | WO2009096559A1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009096560A1 (ja) * | 2008-01-31 | 2009-08-06 | Kyorin Pharmaceutical Co., Ltd. | イミダフェナシン含有口腔内速崩壊性錠剤 |
US20120289563A1 (en) * | 2011-05-10 | 2012-11-15 | Theravida, Inc. | Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladder |
CN103063795B (zh) * | 2012-12-27 | 2015-01-07 | 南京艾德凯腾生物医药有限责任公司 | 咪达那新的含量测定及有关物质检测方法 |
JP6186139B2 (ja) * | 2013-03-08 | 2017-08-23 | 杏林製薬株式会社 | 口腔内速崩壊性錠剤 |
CN104614468B (zh) * | 2015-03-02 | 2020-11-03 | 北京万全德众医药生物技术有限公司 | 一种用高效液相色谱法分离咪达那新及其有关物质的方法 |
EP3395343A4 (en) | 2015-12-25 | 2019-08-21 | Kyorin Pharmaceutical Co., Ltd. | Vasopressin-like action enhancer |
JP6212588B2 (ja) * | 2016-03-24 | 2017-10-11 | 杏林製薬株式会社 | イミダフェナシン含有口腔内速崩錠 |
JP6303044B1 (ja) * | 2017-03-30 | 2018-03-28 | 杏林製薬株式会社 | 押出し造粒法を用いたイミダフェナシンを含有する製剤の製造方法 |
JP6423035B2 (ja) * | 2017-03-30 | 2018-11-14 | 杏林製薬株式会社 | イミダフェナシン含有造粒物のコーティング顆粒 |
JP6435363B2 (ja) * | 2017-03-30 | 2018-12-05 | 杏林製薬株式会社 | 湿式造粒法によるイミダフェナシンを含有する造粒物の製造方法 |
JP6423034B2 (ja) * | 2017-03-30 | 2018-11-14 | 杏林製薬株式会社 | イミダフェナシン含有錠剤 |
JP6435362B2 (ja) * | 2017-03-30 | 2018-12-05 | 杏林製薬株式会社 | 保存安定性に優れたイミダフェナシンを含有する製剤 |
JP6303045B1 (ja) * | 2017-03-30 | 2018-03-28 | 杏林製薬株式会社 | 攪拌造粒法を用いたイミダフェナシンを含有する製剤の製造方法 |
JP2018203789A (ja) * | 2018-10-09 | 2018-12-27 | 杏林製薬株式会社 | 製造工程分解物の少ないイミダフェナシンを含有する造粒物 |
JP2019019148A (ja) * | 2018-11-12 | 2019-02-07 | 杏林製薬株式会社 | 保存安定性に優れたイミダフェナシンを含有する製剤 |
CN110068623B (zh) * | 2019-04-08 | 2022-04-12 | 南京海纳医药科技股份有限公司 | 一种咪达那新中有关物质的检测方法 |
CN110554104B (zh) * | 2019-07-26 | 2022-05-13 | 南京海纳医药科技股份有限公司 | 一种hplc-ms/ms联用检测人血浆中咪达那新的方法 |
CA3203975A1 (en) | 2020-12-03 | 2022-06-09 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
CN117500923A (zh) | 2021-04-07 | 2024-02-02 | 巴特尔纪念研究院 | 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3294961B2 (ja) | 1993-12-10 | 2002-06-24 | 杏林製薬株式会社 | 新規イミダゾール誘導体及びその製造法 |
CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
EP0839526A3 (en) * | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
DE60016381T2 (de) * | 1999-02-15 | 2005-12-15 | Sumitomo Pharmaceuticals Co., Ltd. | Im mundraum schnellzerfallende tabletten |
US20030026835A1 (en) * | 1999-02-15 | 2003-02-06 | Sumitomo Pharmaceuticals Company Limited | Tablets disintegrating rapidly in the oral cavity |
EP1245232B1 (en) | 1999-11-11 | 2006-01-25 | Kyorin Pharmaceutical Co., Ltd. | Oral solid preparation |
US8449911B2 (en) * | 2003-03-12 | 2013-05-28 | Takeda Pharmaceutical Company Limited | Drug composition having active ingredient adhered at high concentration to spherical core |
JP5062871B2 (ja) * | 2003-05-13 | 2012-10-31 | 東和薬品株式会社 | 苦味を低減した口腔内崩壊錠剤 |
US20070021391A1 (en) * | 2003-06-30 | 2007-01-25 | Takayuki Doi | Preventive/remedy for urinary disturbance |
WO2005011682A1 (ja) | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経口徐放性錠剤 |
WO2005011683A1 (ja) | 2003-08-04 | 2005-02-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
EP1787640A4 (en) | 2004-04-30 | 2012-04-11 | Astellas Pharma Inc | GRAINED PHARMACEUTICAL COMPOSITION WITH TEMPORARY DELIVERY FOR ORAL ADMINISTRATION AND FAST-DECREASING INTRAORAL TABLET WITH THE COMPOSITION |
EP1847268A1 (en) * | 2005-01-31 | 2007-10-24 | Kyorin Pharmaceutical Co., Ltd. | Multiple unit oral sustained release preparation and process for production of the same |
KR20130069764A (ko) | 2005-02-03 | 2013-06-26 | 교린 세이야꾸 가부시키 가이샤 | 경피 흡수형 제제 |
-
2009
- 2009-01-30 WO PCT/JP2009/051651 patent/WO2009096559A1/ja active Application Filing
- 2009-01-30 ES ES09705447.2T patent/ES2444718T3/es active Active
- 2009-01-30 CA CA2713677A patent/CA2713677A1/en not_active Abandoned
- 2009-01-30 PT PT97054472T patent/PT2246051E/pt unknown
- 2009-01-30 JP JP2009551623A patent/JP4656672B2/ja active Active
- 2009-01-30 US US12/865,632 patent/US8722133B2/en not_active Expired - Fee Related
- 2009-01-30 KR KR1020107019209A patent/KR101528953B1/ko active Active
- 2009-01-30 EP EP09705447.2A patent/EP2246051B1/en not_active Not-in-force
- 2009-01-30 CN CN200980111934XA patent/CN101983055B/zh active Active
- 2009-01-30 DK DK09705447.2T patent/DK2246051T3/da active
Also Published As
Publication number | Publication date |
---|---|
EP2246051B1 (en) | 2013-12-11 |
JP4656672B2 (ja) | 2011-03-23 |
CN101983055A (zh) | 2011-03-02 |
KR101528953B1 (ko) | 2015-06-15 |
PT2246051E (pt) | 2014-01-07 |
JPWO2009096559A1 (ja) | 2011-05-26 |
US20100323090A1 (en) | 2010-12-23 |
ES2444718T3 (es) | 2014-02-26 |
US8722133B2 (en) | 2014-05-13 |
CN101983055B (zh) | 2013-05-08 |
CA2713677A1 (en) | 2009-08-06 |
WO2009096559A1 (ja) | 2009-08-06 |
EP2246051A4 (en) | 2013-03-06 |
KR20100126335A (ko) | 2010-12-01 |
EP2246051A1 (en) | 2010-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2246051T3 (da) | Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel | |
DK2328601T3 (da) | Linaclotid-holdige formuleringer til oral indgivelse | |
IL249747A0 (en) | Antibacterial oral composition | |
EP2229939A4 (en) | CAPSULE FORMULATION | |
BR112012011733A2 (pt) | formulações de comprimido de liberação imediata | |
DK2462116T3 (da) | Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser | |
BRPI0908114A2 (pt) | tabuleta oral de liberação controlada | |
DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
HK1198287A1 (en) | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives 2--1- | |
BR112012002105A2 (pt) | formulação farmacêutica | |
EP2310363A4 (en) | ORAL ANTIBODY FORMULATIONS | |
EP2246052A4 (en) | RASCH IN THE MOUTH DAMAGING TABLET WITH IMIDAFENACIN | |
BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
BRPI0906754A2 (pt) | Formulário de dosage prolongado da libertação de paliperidone | |
BRPI0921654A2 (pt) | formulação farmacêutica | |
BRPI0918539A2 (pt) | preparação farmacêutica sólida para administração oral | |
BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
BRPI0919194A2 (pt) | preparação sólida para administração oral | |
BRPI0823402A2 (pt) | Formulações farmacêuticas de olmesartan | |
DK2216039T3 (da) | Farmaceutiske sammensætninger til behandling af angst | |
BRPI0923379A2 (pt) | Formulação para administração por via transmucosa oral de setronas | |
BRPI0922623A2 (pt) | comprimido farmacêutico de liberação controlada | |
EP2520300A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
PT2391352T (pt) | Formas farmacêuticas para a libertação de compostos ativos | |
DK2219611T3 (da) | Farmaceutiske formuleringer til frigivelse af aktive forbindelser |